Clinical Trial Update: Therapeutic Equivalence of Diclofenac Sodium Gel 3% vs Solaraze ® in the Treatment of Actinic Keratosis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating whether Diclofenac Sodium Gel 3% is therapeutically equivalent to Solaraze for actinic keratosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• Diclofenac Sodium Gel 3% (diclofenac sodium gel 3%)
• Solaraze (diclofenac sodium)

Snippet

Sponsor: Encube Ethicals Pvt. Ltd. | Conditions: Actinic Keratoses | Phase 3 | Status: COMPLETED